Federal (United States) · Session law
Title I
28 sections
28 sections
- Pub. L. 105-115, tit. I, subtit. A, sec. 101FINDINGS.Enacted
- Pub. L. 105-115, tit. I, subtit. A, sec. 102DEFINITIONS.Enacted
- Pub. L. 105-115, tit. I, subtit. A, sec. 103AUTHORITY TO ASSESS AND USE DRUG FEES.Enacted
- Pub. L. 105-115, tit. I, subtit. A, sec. 104ANNUAL REPORTS.Enacted
- Pub. L. 105-115, tit. I, subtit. A, sec. 105SAVINGS.Enacted
- Pub. L. 105-115, tit. I, subtit. A, sec. 106EFFECTIVE DATE.Enacted
- Pub. L. 105-115, tit. I, subtit. A, sec. 107TERMINATION OF EFFECTIVENESS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 111PEDIATRIC STUDIES OF DRUGS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 112EXPEDITING STUDY AND APPROVAL OF FAST TRACK DRUGS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 113INFORMATION PROGRAM ON CLINICAL TRIALS FOR SERIOUS OR LIFE-THREATENING DISEASES.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 114HEALTH CARE ECONOMIC INFORMATION.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 115CLINICAL INVESTIGATIONS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 116MANUFACTURING CHANGES FOR DRUGS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 117STREAMLINING CLINICAL RESEARCH ON DRUGS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 118DATA REQUIREMENTS FOR DRUGS AND BIOLOGICS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 119CONTENT AND REVIEW OF APPLICATIONS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 120SCIENTIFIC ADVISORY PANELS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 121POSITRON EMISSION TOMOGRAPHY.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 122REQUIREMENTS FOR RADIOPHARMACEUTICALS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 123MODERNIZATION OF REGULATION.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 124PILOT AND SMALL SCALE MANUFACTURE.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 125INSULIN AND ANTIBIOTICS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 126ELIMINATION OF CERTAIN LABELING REQUIREMENTS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 127APPLICATION OF FEDERAL LAW TO PRACTICE OF PHARMACY COMPOUNDING.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 128REAUTHORIZATION OF CLINICAL PHARMACOLOGY PROGRAM.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 129REGULATIONS FOR SUNSCREEN PRODUCTS.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 130REPORTS OF POSTMARKETING APPROVAL STUDIES.Enacted
- Pub. L. 105-115, tit. I, subtit. B, sec. 131NOTIFICATION OF DISCONTINUANCE OF A LIFE SAVING PRODUCT.Enacted